Figure 1.
Flowchart of trials.
Table 1.
Pimecrolimus (Study Characteristics).
Table 2.
Reduction in EASI scores.
Figure 2.
Analysis of reduction in IGA (Pimecrolimus vs vehicle).
Figure 3.
Analysis of reduction in IGA (pimecrolimus vs tacrolimus).
Figure 4.
Analysis of flare free periods (pimecrolimus vs vehicle).
Figure 5.
Analysis of pruritus (pimecrolimus vs vehicle).
Figure 6.
Analysis of pruritus (pimecrolimus vs tacrolimus).
Figure 7.
Analysis of care giver's assessment (pimecrolimus vs pruritus).
Figure 8.
Analysis of total Adverse events.
Figure 9.
Analysis of Study withdrawals.
Figure 10.
Analysis of Study withdrawals due to unsatisfactory therapeutic effects.